2024 Speakers

Paul Stanton

Senior Director, Global Strategy

Inceptua

Rebecca Bibby

Group Director & General Manager - Medicines Access

BAP Pharma Ltd.

Sarah Flynn, Novartis, 3rd Operationalise: Early Access Programmes Europe 2024

Sarah Flynn

Director Managed Access

Novartis

Karlijn Doorn, myTomorrows, 3rd Operationalise: Early Access Programmes Europe 2024

Karlijn Doorn

Head of Partnerships and Customer Success

myTomorrows

Aimee Davidson, Bionical Emas, 3rd Operationalise: Early Access Programmes Europe 2024

Aimee Davidson

Portfolio Director

Bionical Emas

Phoebe Luk, Bionical Emas, 3rd Operationalise: Early Access Programmes Europe 2024

Phoebe Luk

Associate Director, Regulatory Affairs

Bionical Emas

Allison Webb, Blueprint Medicines, 3rd Operationalise: Early Access Programmes Europe 2024

Allison Webb

Senior Project Manager

Blueprint Medicines

Bethany Bearden, Blueprint Bio, 3rd Operationalise: Early Access Programmes Europe 2024

Bethany Bearden

Assoc. Director EAP

Blueprint Medicines

Victoria Scott

Managed Access program (MAP) Lead

Novartis

Olivia Vickery

Patient Advocate

Patient Advocates In Research

Ita Vickery

Mother & Patient Caregiver

Patient Advocates In Research

Harpreet Ram

Executive Director

GARDaccess

Annie Drelles, Daiichi Sankyo, 3rd Operationalise: Early Access Programmes Europe 2024

Annie Drelles

Senior Director - Office of Medical Access, Global Oncology Medical Affairs

Daiichi Sankyo, Inc.

Natalia Coptu

Site Manager Lead

myTomorrows

Margaret Radford

UMSM

Almac

Lyn McNeill

Supply Chain Solutions Manager

Almac

Laura Carr

Executive Director & Head, GOMA Clinical Trial Management

Head GMA Oncology Trial Management, Resources & Operations at Daiichi Sankyo

Nico Laschi

Business Development Manager

Marken

Warsame Ali

Senior Manager Lead, Global Early Access Program

Marken

Anke Friedetzky

Medical Affairs

myTomorrows

Ruth Rostron

Director - Employee Assistance Program

Uniphar Access

Nicky Wisener

Vice President - Business Development, Unlicensed Medicines

Idis Limited

Sarah Alummootil

Associate Director

Early Access Care

Uri Ilan

Clinical researcher PHD Student, Coordinator of the international Leukemia/Lymphoma Target Board

Coordinator of the International Leukemia/Lymphoma Target Board at Prinses Maxima Center for Pediatric Oncology

Alberto Calabro

Patient Access Program & Supply Lead

Roche

Ana Paula Tediosi

Director & Head of Expanded Access Program Strategy & Business Development

WEP Clinical

Ann Watkins

Associate Director, Evidence Optimisation and Managed Access Team, Medical Affairs EUR / International

Jazz Pharmaceuticals Inc

Anne Cropp, Operationalise: Early Access Programmes

Anne Cropp

Chief Scientific Officer

Early Access Care

Ben Rotz

Associate Vice President - Global Medical Policy Strategy & Operations

Eli Lilly

Bethany Jordon, GSK, 3rd Operationalise: Early Access Programmes Europe 2024

Bethany Jordon

Oncology Managed Access Program Lead

GlaxoSmithKline Plc

Carole Scrafton

Director ,Co-F Patient Advocacy Organisation , Social Media Coordinator , Website Manager , Patient & Health Advocate

Flutters and Strutters

Carolina Cela

Medical Affairs Operations Manager

Incyte Corporation

Danielle Rafferty

Associate Director, Medical Operations

Biogen

Dennis Akkaya

Chief Commercial Officer

myTomorrows

Eva Gallagher

Vice President & Head Of Medical Affairs

Agios Pharmaceuticals

Gordon Lundie

Executive Director - Market Access

Gilead Sciences

Helen Dean

Associate Director Medical Affairs

Jazz Pharmaceuticals Inc

Karen Frascello

Senior Director - Medical Affairs & Early Access & Global Diagnostics Expanded & Compassionate Use

Alnylam Pharmaceuticals

Katja Berg

Head of Innovative Value & Strategy, Global Market Access & Pricing, Biopharmaceutical Business Unit

AstraZeneca

Kjersten Teeter

Director, Head of Medical Affairs Operations

Blueprint Medicines

Michael Wrigglesworth, Operationalise: Early Access Programmes

Michael Wrigglesworth

VP Programs Operations

The Max Foundation

Nora Pöntynen

GCO

Boehringer Ingelheim

Petra Stubbe

Mother & Patient Advocate

Early Access Care

Rachel Harrison

Global Medical Affairs & Pre-Approval Access Program Lead

argenx

Ramona Reichenbach

Head MACoE

Novartis AG

Rebecca Bibby

Group Director of Medicines Access & UK General Manager

BAP Pharma

Sara Radenovic

Director - Managed Access Programs

GlaxoSmithKline Plc

Vilem Guryca

Director Expanded Access

BeiGene

2024 FULL EVENT GUIDE